A lower number of tumor infiltrating CD68+ macrophages was associated with resistance to post‐surgery treatment with SRLs (48/HPFs, IQR: 22.9) than in patients responsive to post‐surgical SRL treatment (80/HPFs, IQR: 51, p = .005, Table 3). Here, CD68 is linked to neoplasm.